How Does Ocular Melanoma Immunotherapy in Israel Save Lives and Vision?

TIL immunotherapy for ocular melanoma is a cutting-edge procedure that involves drastically increasing the number of elite cancer-killing lymphocytes in your body that target and attack malignant cells.

Ocular melanoma – cancer that occurs in melanin-producing cells – begins most typically in the middle layer of the eye, the uvea, which is why it is often called uveal melanoma. It is a malignant and aggressive tumor that can remain silent until it has spread to other parts of the body. At that point, it is referred to as metastatic melanoma. In general, TIL immunotherapy is used to treat metastatic melanoma.

Malignant eye tumors are rare, and it’s vital to choose a hospital that is equipped with the technologies, professional experience and expertise to provide optimal care. The Ocular Oncology Center of the Goldschleger Eye Institute at Sheba Medical Center in Israel is the largest of its kind in the country, performing more than 3,800 ocular procedures every year. Sheba offers modern specialized medical techniques, including ocular melanoma TIL immunotherapy.

At Sheba, immunotherapy for ocular melanoma as well as other the most advanced and personalized methods are used to preserve vision, save lives, and maximize quality of life. A holistic approach to medicine is practiced; treatment focuses on the whole person – and not just on the eye disease. Supportive services, rehabilitation and psychological care are just a few of the compassionate, patient-centric features Sheba is proud to offer on-site.